Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2026 ▲▼ | Q3 2026 ▲▼ | Change ▲▼ | Q2 2026 ▲▼ | Q3 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvation Bio Inc.CL A(NUVB) | 8,081,089 | 7,151,031 | -930,058 | $45.90M | $40.05M | 31.99% | -$5.85M |
| Bicara Therapeutics Inc. | 1,822,150 | 1,759,912 | -62,238 | $54.10M | $32.75M | 26.17% | -$21.35M |
| Beta Bionics, Inc.(BBNX) | 1,316,183 | 962,010 | -354,173 | $20.62M | $18.26M | 14.59% | -$2.37M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 3,289,661 | 3,289,661 | 0 | $25.07M | $13.49M | 10.78% | -$11.58M |
| Kestra Med Technologies Ltd SHS | 1,022,149 | 362,394 | -659,755 | $26.00M | $10.25M | 8.19% | -$15.75M |
| Immunic, Inc.(IMUX) | 0 | 430,180 | +430,180 | $0 | $4.00M | 3.20% | +$4.00M |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | $2.94M | $2.46M | 1.97% | -$480.9K |
| ImageneBio, Inc.(IMA) | 455,361 | 455,361 | 0 | $2.69M | $2.09M | 1.67% | -$601.1K |
| enGene Holdings Inc. COM | 876,357 | 876,357 | 0 | $1.52M | $1.75M | 1.40% | +$236.6K |
| Odyssey Therapeutics Inc. | 2,893 | 2,893 | 0 | $54.1K | $64.3K | 0.05% | +$10.2K |
| Alumis Inc. | 241,255 | 0 | -241,255 | $6.79M | $0 | — | -$6.79M |